Alerts
Thursday 06 October 2022 from 13:00 to 14:10
Po.1 E- poster session 1: animal models, omics in lupus, major organ involvement inclucing npsle, organ damage and survival
PO.1.1 Afimetoran, a potent and selective inhibitor of human toll-like receptor 7 (TLR7) and tlr8, provides robust efficacy in a murine lupus model of advanced disease